9siTwo series of naphthoquinone and anthraquinone derivatives decorated with an aromatic/heteroaromatic chain have been synthesized and evaluated as potential promiscuous agents capable of targeting different factors playing a key role in Alzheimer's disease (AD) pathogenesis. On the basis of the in vitro biological profiling, most of them exhibited a significant ability to inhibit amyloid aggregation, PHF6 tau sequence aggregation, acetylcholinesterase (AChE), and monoamine oxidase (MAO) B. In particular, naphthoquinone 2 resulted as one of the best performing multitarget-directed ligand (MTDL) experiencing a high potency profile in inhibiting β-amyloid (Aβ40) aggregation (IC50 = 3.2 μM), PHF6 tau fragment (91% at 10 μM), AChE enzyme (IC50...
none16One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective...
Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE inhibi...
One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disea...
Two series of naphthoquinone and anthraquinone derivatives decorated with an aromatic/heteroaromatic...
Two series of naphthoquinone and anthraquinone derivatives decorated with an aromatic/heteroaromatic...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a neuronal and synaptic lo...
We report the identification of multitarget anti-Alzheimer compounds designed by combining a naphtho...
We report the identification of multitarget anti-Alzheimer compounds designed by combining a naphtho...
none16siWe report the identification of multitarget anti-Alzheimer compounds designed by combining a...
We report the identification of multitarget anti-Alzheimer compounds designed by combining a naphtho...
Based on a multitarget strategy, a series of novel chromanone–1-benzyl-1,2,3,6-tetrahydropyridin hyb...
Multitarget therapeutic leads for Alzheimer's disease were designed on the models of compounds capab...
none11Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE ...
Abstract Multitarget therapeutic leads for Alzheimer's disease were designed on the models of compou...
One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disea...
none16One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective...
Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE inhibi...
One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disea...
Two series of naphthoquinone and anthraquinone derivatives decorated with an aromatic/heteroaromatic...
Two series of naphthoquinone and anthraquinone derivatives decorated with an aromatic/heteroaromatic...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a neuronal and synaptic lo...
We report the identification of multitarget anti-Alzheimer compounds designed by combining a naphtho...
We report the identification of multitarget anti-Alzheimer compounds designed by combining a naphtho...
none16siWe report the identification of multitarget anti-Alzheimer compounds designed by combining a...
We report the identification of multitarget anti-Alzheimer compounds designed by combining a naphtho...
Based on a multitarget strategy, a series of novel chromanone–1-benzyl-1,2,3,6-tetrahydropyridin hyb...
Multitarget therapeutic leads for Alzheimer's disease were designed on the models of compounds capab...
none11Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE ...
Abstract Multitarget therapeutic leads for Alzheimer's disease were designed on the models of compou...
One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disea...
none16One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective...
Memoquin (1) is a lead compound multitargeted against Alzheimer's disease (AD). It is an AChE inhibi...
One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disea...